Supplementary Figures 1-8 from The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors

MLA

Joan M. Carboni, et al. Supplementary Figures 1-8 from The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors. Mar. 2023. EBSCOhost, https://doi.org/10.1158/0008-5472.22376792.v1.

APA

Joan M. Carboni, Ashok Dongre, Ricardo M. Attar, Lee Helman, Edwin Clark, Marco M. Gottardis, Francis Y. Lee, Aixin Li, Douglas Robinson, Jiwen Chen, Karen Reeves, Gayle M. Wittenberg, Rameh Hafezi, Xia Han, Warren Hurlburt, Ann Greer, & Fei Huang. (2023). Supplementary Figures 1-8 from The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors. https://doi.org/10.1158/0008-5472.22376792.v1

Chicago

Joan M. Carboni, Ashok Dongre, Ricardo M. Attar, Lee Helman, Edwin Clark, Marco M. Gottardis, Francis Y. Lee, et al. 2023. “Supplementary Figures 1-8 from The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors,” March. doi:10.1158/0008-5472.22376792.v1.